The equine herpesviruses.

The research article presents a study on two types of equine herpesviruses, EHV-1 and EHV-4, which were previously believed to cause ‘equine rhinopneumonitis virus’. The paper explores their differences, the diseases they cause, and the effectiveness of current vaccines and management strategies in limiting outbreaks.

Analysis of EHV-1 and EHV-4 Viruses

• The paper examines two equine herpesviruses, named EHV-1 and EHV-4. These viruses were previously grouped under the term ‘equine rhinopneumonitis virus’, which is a type of upper respiratory tract disease in horses.
• The research suggests that while these viruses share several clinical and laboratory characteristics, they impact horses in different ways and present distinct epidemiological and pathogenic potentials.
• EHV-4, according to the study, is mostly related to respiratory disease in horses, while EHV-1 is more often found in aborted foetuses, sick foals, and neurological cases.

Latency and Clinical Impact

• The study explains that both EHV-1 and EHV-4 often establish latent infections, meaning the viruses remain dormant in the horse’s body, potentially reactivating at a later date. However, the research states that the significance of this latency in relation to the clinical disease manifestation is not clear.

Diagnosis and Vaccination

• As per the researchers, diagnosing the disease based on the identification of the specific pathogen involved is generally more effective than methods that rely on serology (the study of blood serum).
• The paper also mentions that vaccines for each virus exist. When these vaccinations are combined with careful management strategies, it can help limit the number of clinical disease cases in horses.

Immunization Challenges

• The study, however, notes that the immunity provided by both vaccination and disease contraction is not absolute. In other words, horses may not necessarily be fully protected from the disease despite vaccination or previous infection.
• The researchers suggest that improved disease prevention may hinge on a deeper understanding of the protective immune responses and how they can be triggered reliably in horses.